Abstract
The present invention relates to the in vitro use of a group of cell-penetrating conjugate systems or a formulation incorporating the same for transporting e.g. therapeutically active agents, such as chemotherapeutics, insulin and immunosuppressants across the cellular membranes of mammalian cells, including human cells. The invention also relates to an in vitro methods of transporting physiologically active agents, such as therapeutics, across cell-membranes by using the cell-penetrating conjugate systems according to the present invention as well as the cell-penetrating conjugate systems for use in treatment of cancer, diabetes and for use in immunotherapy.
Original language | English |
---|---|
IPC | A61K 47/ 18 A I |
Patent number | WO2020207974 |
Filing date | 06/04/2020 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 10/04/2019 |
Priority number | EP20190168314 |
Publication status | Published - 15 Oct 2020 |